FreeStyle Libre 2 system
FreeStyle Libre 2 system
FreeStyle Libre 2 system

Advanced technology designed to fit into your patients’ lives. 

FreeStyle Libre 3 is continuous glucose monitoring (CGM) system that streams minute-to-minute glucose readings directly to your patients’ smartphones,◊◊ enabling patients to act faster to reduce hypoglycaemia.

FSL3 CGM

Performance your patients can count on

Glucose readings every minute of every hour of every day for up to 14 days 

5x more readings power up to 5x faster alarms2

Patients can view their minute-to-minute glucose data with a quick glance of their smartphones◊◊

Discreet

Smaller than the size of a £1 coin easy to wear4 with a discreet4 sensor for up to
14 days.

Patients simply scan to activate the sensor – no finger pricking or code entry is required.

Easy

The sensor is easy to apply4 using a one-piece applicator. It requires no in-person training to use.

The sensor can be worn while patients shower, swim and exercise.T

5x more reading power up to 5x faster alarms5,6

The sensor sends glucose readings directly to patients’ smartphones2 every minute to provide complete glycaemic profiles7, so you can make informed treatment decisions.

Minute-to-minute readings, enable your patients to act facter to reduce hypoglycaemia

Graph showing blood glucose in recommended range over time.

38%

38% reduction in time spent in hypoglycaemia without increasing HbA1c8

Graph showing blood glucose in recommended range over time.

40%

40% reduction in nocturnal hypoglycaemia8

Graph showing blood glucose in recommended range over time.

50%

50% reduction in serious hypoglycaemia (≤3.0 mmol/L)8

Excellent, reliable glucose alarms so your patients, caregivers have peace of mind 6,9

The fully customisable glucose alarms allow users to set high and low glucose alarm thresholds, based on individual needs and preferences. Alarms let patients know the minute they’ve crossed the preset thresholds, allowing them to take action to manage their glucose levels.

Three optional sound/vibration alarms alert patients to:

FSL3 App FSL3 Reader
  • Low glucose levels 
  • High glucose levels 
  • Signal loss 

 

Outperforms other continuous glucose monitoring systems in connectivity2,4 

The FreeStyle Libre 3 sensor has wider signal range and fewer signal losses, with only one signal loss (>10 minutes) every four days on average compared to every 12 hours (10 minutes) for other leading brands.4 In the event of signal loss, the system reconnects in just 30 seconds4 on average, so patients won't miss a possible hypo. 14-day sensor data storage means no data gaps in recording. 

The FreeStyle Libre 3 system has a range of 10 metres, compared to 6 metres for other leading brands The FreeStyle Libre 3 system has a range of 10 metres, compared to 6 metres for other leading brands

Significant improvement in clinical outcomes10 and quality of life11

As the most accurate 14-day continuous glucose monitoring system12, FreeStyle Libre 3 empowers patients to act faster
to avoid hypoglycaemia. It can help reduce time spent in hypoglycaemia8,13 and improve overall glucose control for patients.10,14  Find out more about the accuracy and reliability of the FreeStyle Libre 3 system.

fsl3

95% of patients have a better understanding of their glucose fluctuations11


 
 

fsl3

1hr more Time in Range per
day compared to finger
pricking8



 

fsl3

0.55% reduction of HbA1c at at
2-4 months and sustained at
month 12 in adults and
children with T1D and adults
with T2D.10

NOTE: statistically significant HbA1c reduction based on the confidence interval range.

Studies data collected with FreeStyle Libre system and are applicable to the FreeStyle Libre 3 system based on technological similarities.

Accuracy

The FreeStyle Libre 3 system has a MARD below 8%

  • 7.8% Overall MARD15

  • 93.4% Within ± 20% / ± 1.1 mmol/L15

    Percentage of readings within ± 1.1 mmol/L of YSI values for glucose levels < 3.9 mmol/L and ± 20% when ≥ 3.9 mmol/L.

  • 99.9% in Zones A and B of Consensus Error Grid4

Graph showing the YSI reference

Comprehensive glycaemic reports in LibreView

Graph showing blood glucose in recommended range over time.

Quickly assess your patient’s Time In Ranges in a single-page, comprehensive report

Graph showing blood glucose in recommended range over time.

Provides further details, treatment, and personalised medication considerations to help you manage your patient’s diabetes

Graph showing blood glucose in recommended range over time.

A quick overview of your patient’s daily insulin usage to help make treatment adjustments

   

Connections & Partnerships

Accurate, minute-to-minute glucose data combined with automated insulin delivery

The FreeStyle Libre 3 sensor delivers minute-to-minute glucose readings and is authorised to work with the mylife Loop AID system.

The FreeStyle Libre 3 sensor working with the mylife Loop AID system

   

FreeStyle Libre 3 App

The FreeStyle Libre 3 app◊◊ allows patients to interpret their glucose data from the FreeStyle Libre 3 sensor on their smartphone anytime, anywhere.

    

LibreView

LibreView,our secure16 cloud-based system, allows patients to share their glucose data with Healthcare Professionals. When connected, you will be able to access more in-depth reports to support you in making treatment decisions for your patients.

    

LibreLinkUp

Patients who use the FreeStyle Libre 3 app◊◊ can remotely share their glucose readings with their caregivers and loved ones through the LibreLinkUp app.§
 

Prescribing guidance

For all adults with Type 1 diabetes (T1DM)17

NICE guidelines now support the use of the FreeStyle Libre 3 system (rtCGM18) in all adults aged 18 and over with T1DM.17

Healthcare professional advising patient

If your patient is an adult with Type 2 diabetes (T2D MDI),19  the FreeStyle Libre 2 system might be right for them

NICE guidelines support the use of FreeStyle Libre 2 system in selected adults with type 2 diabetes on MDI.20

 

NICE now recommends HCL Systems For Selected People with T1D4-11

The new NICE technology appraisal recommendation means more type 1 patients qualify for a Hybrid Closed (HCL) compatible real-time CGM system.

Patients can improve glycaemic control with the mylife Loop AID system, authorised to work with the FreeStyle Libre 3 sensor. 

A healthcare professional and a patient looking at a computer monitor together.

References & Disclaimers

Images are for illustrative purposes only. Not real patient data.

1. Data on file, Abbott Diabetes Care, Inc. Based on the number of users worldwide for the FreeStyle Libre portfolio compared to the number of users for 
other leading personal use sensor-based glucose monitoring systems.

2. Based on signal range in Dexcom G6 CGM User Guide and Medtronic Guardian Connect System User Guide.

3. Among patient-applied sensors.

4. Data on file, Abbott Diabetes Care, Inc.

5. Dexcom G6 CGM User Guide and Medtronic Guardian Connect System User Guide.
6. Notifications will only be received when alarms are turned on and the sensor is within 10 meters unobstructed of the reading device.
7. Unger, J. et al, Postgrad Med. (2020): https://doi.org/10.1080/00325481.2020.1744393.
8. Bolinder, J. et al. Lancet (2016): http://doi.org/10.1016/S0140-6736(16)31535-5.

9. Hilliard, M., et al. Diabetes Technology & Therapeutics. (2019): https:/doi.org/10.1089/dia.2019.0142
10. Evans, M. et al. Diabetes Ther (2020): https://doi.org/10.1007/s13300-019-00720-0.

11. Fokkert, M. et al. BMJ Open Diab Res Care (2019): https://doi.org/10.1136/bmjdrc-2019-000809.

12. Alva, S. et al. Diabetes Ther. (2023); doi: 10.1007/s13300-023-01385-6.
13. Haak, T. et al. Diabetes Ther. (2017): https://doi.org/10.1007/s13300-016-0223-6.
14. Yaron, M. et al. Diabetes Care (2019): https://doi.org/10.2337/dc18-0166.

15. FreeStyle Libre 3 User Manual. FreeStyle Libre 3 demonstrates 7.8% overall MARD with 7.5% adult MARD and 8.6% paediatric MARD (age 6-17) in accuracy to YSI.
16. LibreView is ISO27001/27018/27701 certified and HITRUST CSF Certified.
17. NICE guideline NG17 (2015) Last updated: 17 August 2022; available at https://www.nice.org.uk/guidance/ng17. Accessed Jan 2023.
18. Real-time continuous glucose monitoring.
19. Multiple daily insulin injections.
20. NICE guideline NG28 (2015) Last updated: 29 June 2022; available at https://www.nice.org.uk/guidance/ng28. Accessed Jan 2023.
◊◊ The FreeStyle Libre 3 app is only compatible with certain mobile devices and operating systems. Please check our website for more information about device compatibility before using the app. Sharing of glucose data requires registration with LibreView.
₼ The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose device data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.
§ The LibreLinkUp app is only compatible with certain mobile device and operating systems. Please check www.LibreLinkup.com for more information about device compatibility before using the app. Use of LibreLinkUp requires registration with LibreView. The LibreLinkUp mobile app is not intended to be a primary glucose monitor: home users must consult their primary device(s) and consult a healthcare professional before making any medical interpretation and therapy adjustments from the information provided by the app.
‡ 60-minute warm-up period required when applying the sensor.
₸ Sensor is water resistant in up to 1 metre (3 feet) of water for a maximum of 30 minutes. Do not immerse longer than 30 minutes. Not to be used above 10,000 feet.

Loading...